Emergent Biosolutions reported $301.1M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 228.48M 53.07M
Akebia Therapeutics AKBA:US $ 120.19M 5.57M
Alnylam Pharmaceuticals ALNY:US $ 359.99M 93.1M
Amarin AMRN:US 122.94M 5.42M
Ani Pharmaceuticals ANIP:US $ 83.67M 980K
Biomarin Pharmaceutical BMRN:US $ 382.03M 133.66M
Chimerix CMRX:US 24.79M 14.79M
Coherus Biosciences CHRS:US $ 147.26M 34.34M
Emergent Biosolutions EBS:US $ 301.1M 144.7M
Exact Sciences EXAS:US $ 663.56M 31.7M
Exelixis EXEL:US $ 272.74M 61.76M
Glaxosmithkline GSK:US 6.98B 1.65B
Heron Therapeutics HRTX:US $ 86.38M 12.19M
Immunogen IMGN:US $ 60.93M 1.62M
Intercept Pharmaceuticals ICPT:US $ 98.85M 14.42M
Ironwood Pharmaceuticals IRWD:US $ 39.68M 20.86M
JAZZ PHA JAZZ:US $ 726.17M 121.18M
Lexicon Pharmaceuticals LXRX:US 23.42M 1.93M
Lonza Group LONN:SW 2.33B 108M
Merk MRK:US $ 10332M 386M
Moderna Inc MRNA:US 1.84B 38M
Myriad Genetics MYGN:US $ 190.5M 13.4M
Nektar Therapeutics NKTR:US $ 141.38M 3.46M
Neurocrine Biosciences NBIX:US $ 307.5M 40.8M
Opko Health OPK:US $ 401.64M 62.77M
Pacira Pharmaceuticals PCRX:US $ 140.6M 14.38M
Pfizer PFE:US $ 15788M 3271M
Ptc Therapeutics PTCT:US $ 235.26M 14.7M
Sarepta Therapeutics SRPT:US $ 297.71M 9.56M
Seattle Genetics SGEN:US $ 559.51M 42.41M
Teva Pharmaceutical Industries TEVA:US 4.37B 352M
United Therapeutics UTHR:US $ 175.6M 69.8M
Vanda Pharmaceuticals VNDA:US $ 67.86M 8.48M
Xoma XOMA:US $ 5.17M 408K